Cargando…
Neuropharmacology in traumatic brain injury: from preclinical to clinical neuroprotection?
Traumatic brain injury (TBI) constitutes a major health problem worldwide and is a leading cause of death and disability in individuals, contributing to devastating socioeconomic consequences. Despite numerous promising pharmacological strategies reported as neuroprotective in preclinical studies, t...
Autores principales: | Lerouet, Dominique, Marchand‐Leroux, Catherine, Besson, Valérie C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290810/ https://www.ncbi.nlm.nih.gov/pubmed/33527472 http://dx.doi.org/10.1111/fcp.12656 |
Ejemplares similares
-
Traumatic Brain Injury: An Age-Dependent View of Post-Traumatic Neuroinflammation and Its Treatment
por: Delage, Clément, et al.
Publicado: (2021) -
From positron emission tomography to cell analysis of the 18-kDa Translocator Protein in mild traumatic brain injury
por: Delage, Clément, et al.
Publicado: (2021) -
Microglia and Neuroinflammation: What Place for P2RY12?
por: Gómez Morillas, Albert, et al.
Publicado: (2021) -
Neuropharmacological Mechanisms Underlying the Neuroprotective Effects of Methylphenidate
por: Volz, T.J
Publicado: (2008) -
The Neuroprotective Role of Polydatin: Neuropharmacological Mechanisms, Molecular Targets, Therapeutic Potentials, and Clinical Perspective
por: Fakhri, Sajad, et al.
Publicado: (2021)